11 – 20 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Predictors of mortality in patients with different apolipoprotein E genotypes—a 20-year follow-up of Alzheimer’s disease.
2021) 15th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2021)(
- Contribution to conference › Abstract
-
Mark
Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease
(
- Contribution to journal › Article
-
Mark
Medications causing potential cognitive impairment are common in nursing home dementia units – A cross-sectional study
(
- Contribution to journal › Article
-
Mark
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture
(
- Contribution to journal › Article
- 2020
-
Mark
β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
The interaction effect of sex and apolipoprotein E genotype in Alzheimer’s disease—rates of progression and prognosis.
2020) Advances in Alzheimer's and Parkinson's Therapies (AAT-AD/PD) Focus Meeting 2020(
- Contribution to conference › Abstract
-
Mark
Reporting frequency of radiology findings increases after introducing visual rating scales in the primary care diagnostic work up of subjective and mild cognitive impairment
2020) In European Radiology(
- Contribution to journal › Article
- 2019
-
Mark
Structural imaging findings on non-enhanced computed tomography are severely underreported in the primary care diagnostic work-up of subjective cognitive decline
(
- Contribution to journal › Article
-
Mark
Living with dementia with Lewy bodies: an interpretative phenomenological analysis
(
- Contribution to journal › Article